Tumor-infiltrating myeloid cells (TIMs) comprise monocytes, macrophages, dendritic
cells and neutrophils, and have emerged as key regulators of cancer growth. These
cells can diversify into a spectrum of states, which may promote or limit tumor outgrowth,
but remain poorly understood. Here, we used single-cell RNA sequencing to map TIMs
in non-small cell lung cancer patients. We uncovered 25 TIM states, most of which
were reproducibly found across patients. To facilitate translational research of these
populations, we also profiled TIMs in mice. In comparing TIMs across species, we identified
a near-complete congruence of population structures among dendritic cells and monocytes;
conserved neutrophil subsets; and species differences among macrophages. By contrast,
myeloid cell population structures in patients’ blood showed limited overlap with
those of TIMs. This study determines the lung TIM landscape and sets the stage for
future investigations into the potential of TIMs as immunotherapy targets. Tumor-infiltrating
myeloid cells (TIM) have emerged as key cancer regulators and potential next-generation
immunotherapy targets, yet they remain incompletely understood. Using single cell
RNA-seq, Zilionis et al. map the TIM landscape in human and murine lung tumors and
systematically compare cell states, revealing conserved myeloid populations across
individuals and species.